Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
GH has potent effects on adipocyte biology, stimulating lipolysis but also promoting preadipocyte proliferation. In addition, GH, acting through IGF-I, inhibits 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which converts the inactive glucocorticoid, cortisone (E), to active cortisol (...
Main Authors: | Tomlinson, J, Crabtree, N, Clark, P, Holder, G, Toogood, A, Shackleton, C, Stewart, P |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2003
|
פריטים דומים
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
מאת: Tomlinson, J, et al.
יצא לאור: (2001) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
מאת: Tomlinson, J, et al.
יצא לאור: (2004) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
מאת: Stewart, P, et al.
יצא לאור: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
מאת: Tomlinson, J, et al.
יצא לאור: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
מאת: Tomlinson, J, et al.
יצא לאור: (2000)